Kamada VP Orit Pinchuk receives two stock option awards

The awards vest in four equal installments, with 25% vesting on each of the four anniversaries of the grant date.

Rhea-AI Filing Summary

KAMADA LTD (KMDA) reported two employee stock-option awards associated with Orit Pinchuk, VP Regulatory Affairs, dated August 27, 2026, covering 15,000 and 60,000 ordinary shares. The options are held by a trustee under the Company's 2011 Share Award Plan, with exercise prices of $5.98 and $7.44 per share, respectively. The prices were adjusted in connection with a special cash dividend declared August 17, 2026, with a record date of August 27, 2026. Options vest in four equal installments, 25% on each grant-date anniversary. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Grant/Award: 75,000 shares

Grant/Award 2 txns

Insider Pinchuk Orit

Role VP Regulatory Affairs

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy) F1, F4, F2, F3	15,000	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) F1, F5, F2, F3	60,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (right to buy) — 75,000 contracts (Indirect, Held by trustee)

Footnotes (5)

1. F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
2. F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
3. F3. Held by trustee under the Company's 2011 Share Award Plan.
4. F4. This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. F5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Key Figures

Option award, underlying ordinary shares: 15,000 ordinary shares Exercise price: $5.98 per share Option award, underlying ordinary shares: 60,000 ordinary shares +2 more

5 metrics

Option award, underlying ordinary shares 15,000 ordinary shares Award dated August 27, 2026; held by trustee under the 2011 Share Award Plan

Exercise price $5.98 per share For options covering 15,000 ordinary shares; presented in USD

Option award, underlying ordinary shares 60,000 ordinary shares Award dated August 27, 2026; held by trustee under the 2011 Share Award Plan

Exercise price $7.44 per share For options covering 60,000 ordinary shares; presented in USD

Vesting installment 25% Each of four anniversaries of the grant date

Key Terms

Employee Stock Option (right to buy), 2011 Share Award Plan, exercise prices, vest in four equal installments, +1 more

5 terms

Employee Stock Option (right to buy) financial

"Employee Stock Option (right to buy)"

2011 Share Award Plan financial

"Held by trustee under the Company's 2011 Share Award Plan."

exercise prices financial

"The exercise prices of all options reported in this Form 4"

vest in four equal installments financial

"Options vest in four equal installments"

special cash dividend distribution financial

"in connection with a special cash dividend distribution"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What option awards did KMDA report for Orit Pinchuk?

KAMADA LTD reports awards covering 15,000 and 60,000 ordinary shares in employee stock options associated with Orit Pinchuk, VP Regulatory Affairs, dated August 27, 2026. Their exercise prices are $5.98 and $7.44 per share, respectively. The prices are presented in U.S. dollars using the Bank of Israel NIS/USD exchange rate as of September 22, 2026. No Rule 10b5-1 plan is reported.

How do KMDA's reported options vest?

The options vest in four equal installments, with 25% vesting on each of the four anniversaries of the grant date.

Why were KMDA's option exercise prices adjusted?

The exercise prices were adjusted in connection with a special cash dividend distribution declared by the board on August 17, 2026, with a record date of August 27, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/23/2026 - 04:01 PM Accepted by SEC EDGAR 09/23/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pinchuk Orit

(Last) (First) (Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Regulatory Affairs

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$5.98(1)(4)	08/27/2026		A		15,000		(2)	(2)	Ordinary Shares	15,000	$0.00	15,000	I	Held by trustee(3)
Employee Stock Option (right to buy)	$7.44(1)(5)	08/27/2026		A		60,000		(2)	(2)	Ordinary Shares	60,000	$0.00	60,000	I	Held by trustee(3)

Explanation of Responses:

1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

3. Held by trustee under the Company's 2011 Share Award Plan.

4. This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

	/s/ Orit Pinchuk	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)